Avalo Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2015 to 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Avalo Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2015 to 2024.
  • Avalo Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 4.43M shares, a 1494% increase year-over-year.
  • Avalo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 4.43M shares, a 1494% increase from 2023.
  • Avalo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 278K shares, a 608% increase from 2022.
  • Avalo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 39.2K shares.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 4.43M +4.15M +1494% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 278K +239K +608% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 39.2K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2018 34.8M +16.4M +88.9% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-18
2017 18.4M +9.58M +108% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 8.83M +6.6M +297% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 2.23M Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.